Catalent CTLT Stock
Catalent Price Chart
Catalent CTLT Financial and Trading Overview
Catalent stock price | 56.3 USD |
Previous Close | 42.09 USD |
Open | 42.12 USD |
Bid | 31.5 USD x 900 |
Ask | 51.23 USD x 800 |
Day's Range | 42.05 - 43.95 USD |
52 Week Range | 31.45 - 115.34 USD |
Volume | 3.5M USD |
Avg. Volume | 4.79M USD |
Market Cap | 7.86B USD |
Beta (5Y Monthly) | 1.180985 |
PE Ratio (TTM) | 181.625 |
EPS (TTM) | -7.18 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 50 USD |
CTLT Valuation Measures
Enterprise Value | 12.47B USD |
Trailing P/E | 181.625 |
Forward P/E | 28.122581 |
PEG Ratio (5 yr expected) | 8.02 |
Price/Sales (ttm) | 1.7481772 |
Price/Book (mrq) | 1.6683252 |
Enterprise Value/Revenue | 2.773 |
Enterprise Value/EBITDA | 14.666 |
Trading Information
Catalent Stock Price History
Beta (5Y Monthly) | 1.180985 |
52-Week Change | -57.47% |
S&P500 52-Week Change | 20.43% |
52 Week High | 115.34 USD |
52 Week Low | 31.45 USD |
50-Day Moving Average | 43.31 USD |
200-Day Moving Average | 57.57 USD |
CTLT Share Statistics
Avg. Volume (3 month) | 4.79M USD |
Avg. Daily Volume (10-Days) | 4.98M USD |
Shares Outstanding | 180.27M |
Float | 179.51M |
Short Ratio | 1.33 |
% Held by Insiders | 0.36% |
% Held by Institutions | 105.82% |
Shares Short | 8.16M |
Short % of Float | 5.07% |
Short % of Shares Outstanding | 4.53% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | 0.48% |
Operating Margin (ttm) | 9.83% |
Gross Margin | 28.63% |
EBITDA Margin | 18.91% |
Management Effectiveness
Return on Assets (ttm) | 2.61% |
Return on Equity (ttm) | 0.47% |
Income Statement
Revenue (ttm) | 4.5B USD |
Revenue Per Share (ttm) | 25.11 USD |
Quarterly Revenue Growth (yoy) | -18.50% |
Gross Profit (ttm) | 1.64B USD |
EBITDA | 850M USD |
Net Income Avi to Common (ttm) | 21M USD |
Diluted EPS (ttm) | 0.24 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 252M USD |
Total Cash Per Share (mrq) | 1.4 USD |
Total Debt (mrq) | 4.86B USD |
Total Debt/Equity (mrq) | 103.34 USD |
Current Ratio (mrq) | 1.841 |
Book Value Per Share (mrq) | 26.128 |
Cash Flow Statement
Operating Cash Flow (ttm) | 127M USD |
Levered Free Cash Flow (ttm) | -508000000 USD |
Profile of Catalent
Country | United States |
State | NJ |
City | Somerset |
Address | 14 Schoolhouse Road |
ZIP | 08873 |
Phone | 732 537 6200 |
Website | https://www.catalent.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 19000 |
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.
Q&A For Catalent Stock
What is a current CTLT stock price?
Catalent CTLT stock price today per share is 56.3 USD.
How to purchase Catalent stock?
You can buy CTLT shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Catalent?
The stock symbol or ticker of Catalent is CTLT.
Which industry does the Catalent company belong to?
The Catalent industry is Drug Manufacturers-Specialty & Generic.
How many shares does Catalent have in circulation?
The max supply of Catalent shares is 180.74M.
What is Catalent Price to Earnings Ratio (PE Ratio)?
Catalent PE Ratio is now.
What was Catalent earnings per share over the trailing 12 months (TTM)?
Catalent EPS is -7.18 USD over the trailing 12 months.
Which sector does the Catalent company belong to?
The Catalent sector is Healthcare.
Catalent CTLT included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P 500 INDEX SPX | 5123.41 USD — |
-1.46
|
2.41B USD — | 5107.94 USD — | 5175.03 USD — | — - | 2.41B USD — |
S&P 500 (Yahoo.com) GSPC | 5123.41 USD — |
-1.46
|
2.41B USD — | 5107.94 USD — | 5175.03 USD — | — - | 2.41B USD — |
Nasdaq US Smart Pharmaceuticals NQSSPH | 1383.38 USD — |
-2.07
|
— — | 1380.57 USD — | 1408.57 USD — | — - | — — |
NYSE COMPOSITE (DJ) NYA | 17639.04 USD — |
-1.54
|
— — | — — | — — | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
- {{ link.label }} {{link}}